Kukje Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	93,260	103,034	119,890	106,115	112,861	176,865
Market Cap Growth	-12.43%	-14.06%	12.98%	-5.98%	-36.19%	118.14%
Enterprise Value	105,625	124,008	140,751	127,215	143,804	207,752
Last Close Price	4580.00	5028.70	5883.38	5205.69	5534.71	8670.79
PE Ratio	13.07	19.80	-	29.83	-	80.28
PS Ratio	0.54	0.66	0.89	0.84	0.94	1.36
PB Ratio	0.98	1.15	1.41	1.43	1.65	2.51
P/TBV Ratio	0.99	1.16	1.43	1.45	1.67	2.54
P/FCF Ratio	9.90	100.14	47.40	20.23	14.65	-
P/OCF Ratio	8.52	26.15	33.53	16.32	11.76	34.68
EV/Sales Ratio	0.61	0.79	1.04	1.00	1.20	1.59
EV/EBITDA Ratio	8.90	12.52	63.55	13.03	52.42	21.49
EV/EBIT Ratio	12.18	18.50	-	24.13	-	34.39
EV/FCF Ratio	11.21	120.53	55.65	24.26	18.66	-
Debt / Equity Ratio	0.32	0.33	0.36	0.39	0.53	0.54
Debt / EBITDA Ratio	2.57	2.98	13.84	2.93	13.12	3.94
Debt / FCF Ratio	3.23	28.68	12.12	5.45	4.67	-
Asset Turnover	1.01	0.95	0.90	0.92	0.84	0.93
Inventory Turnover	3.42	3.39	3.14	3.27	3.42	3.43
Quick Ratio	0.74	1.13	0.53	0.54	0.58	0.51
Current Ratio	1.19	2.00	0.92	1.01	0.88	0.90
Return on Equity (ROE)	7.71%	5.97%	-10.58%	4.97%	-2.24%	3.34%
Return on Assets (ROA)	3.16%	2.55%	-0.83%	2.38%	-0.73%	2.70%
Return on Invested Capital (ROIC)	6.35%	4.90%	-1.97%	4.06%	-1.67%	2.48%
Return on Capital Employed (ROCE)	7.30%	4.90%	-1.90%	5.90%	-2.00%	6.70%
Earnings Yield	7.65%	5.05%	-7.02%	3.35%	-1.38%	1.25%
FCF Yield	10.11%	1.00%	2.11%	4.94%	6.83%	-3.67%
Dividend Yield	0.65%	0.60%	-	-	-	-
Payout Ratio	8.56%	-	-	-	-	-
Buyback Yield / Dilution	-0.22%	-0.53%	0.03%	0.03%	0.03%	0.00%
Total Shareholder Return	0.43%	0.07%	0.03%	0.03%	0.03%	0.00%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.